List of insiders holdings for SOLIGENIX INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CAVAZZA CLAUDIO 10% Owner | 2010-06-28 16:15:57 | 67,599,044 0 | 67,599,044 | Form 13D |
| BAM Management LLC Berman Ross Mintz Hal 10% Owner | 2010-08-20 14:01:45 | 0 25,558,661 | 25,558,661 | Form 3 |
| Biotex Pharma Investments LLC 10% Owner | 2009-11-12 15:10:25 | 18,750,000 0 | 18,750,000 | Form 4 |
| Buhrman Cyrille F Director | 2009-07-09 16:51:53 | 5,150,020 0 | 5,150,020 | Form 4 |
| SIGMA TAU FINANZIARIA SPA SIGMA TAU INTERNATIONAL SA Sigma-Tau America S.A. Sigma-Tau Pharmaceuticals Inc. 10% Owner | 2013-05-16 15:11:31 | 3,379,950 0 | 3,379,950 | Form 13D |
| KANZER STEVE H Director | 2007-02-13 07:55:14 | 2,398,401 0 | 2,398,401 | Form 4 |
| SEMBER MICHAEL T Chief Executive Officer | 2006-04-10 16:54:37 | 2,360,880 0 | 2,360,880 | Form 4/A |
| HAIG ALEXANDER M JR GENERAL USA RET Director | 2004-11-16 17:27:43 | 2,100,000 0 | 2,100,000 | Form 4 |
| ELLISON RALPHA CEO/President | 2003-09-18 18:56:47 | 2,000,000 0 | 2,000,000 | Form 4 |
| ELAN CORP PLC ELAN INTERNATIONAL SERVICES LTD ELAN PHARMACEUTICAL INVESTMENTS II LTD 10% Owner | 2006-02-13 12:12:16 | 1,219,438 0 | 1,219,438 | Form 13D |
| ELAN CORP PLC ELAN INTERNATIONAL SERVICES LTD ELAN PHARMACEUTICAL INVESTMENTS LTD 10% Owner | 2006-02-13 12:14:01 | 1,219,438 0 | 1,219,438 | Form 13D |
| MYRIANTHOPOULOS EVAN Sr VP and CFO | 2011-12-02 16:08:34 | 1,200,000 0 | 1,200,000 | Form 4 |
| Haig Alexander P Director | 2006-01-12 16:01:42 | 1,050,000 0 | 1,050,000 | Form 4 |
| Salomon Peter Director | 2004-11-16 17:29:29 | 820,000 0 | 820,000 | Form 4/A |
| HAMILTON BRIAN L Chief Medical Officer & Sr VP | 2010-09-27 16:48:40 | 800,000 0 | 800,000 | Form 4 |
| SCHNITTKER CHRISTOPHER P. VP-Admin., Controller | 2010-09-27 16:49:50 | 700,000 0 | 700,000 | Form 4 |
| Clavijo James Controller/Treasurer | 2008-12-19 16:32:36 | 600,000 0 | 600,000 | Form 4 |
| Davenport Gregory President Biodefense Division | 2004-10-22 11:17:02 | 500,000 0 | 500,000 | Form 3 |
| KESSEL LARRY Director | 2004-11-16 17:23:44 | 400,000 0 | 400,000 | Form 4/A |
| Robertson George A VP Research & Development | 2005-03-14 17:51:43 | 300,000 0 | 300,000 | Form 3 |
| Essetifin SPA CAVAZZA PAOLO Leadiant Biosciences Inc. Cavazza Enrico Cavazza Francesca Cavazza Silvia Cavazza Preta Martina Former 10% Owner | 2017-12-01 16:25:01 | 293,510 0 | 293,510 | Form 4 |
| KIRK RANDAL J INTREXON CORP 10% Owner | 2017-06-16 17:24:59 | 277,631 0 | 277,631 | Form 13D |
| KUO JAMES S Director | 2009-07-09 16:39:52 | 250,000 0 | 250,000 | Form 4 |
| KORNBLUTH ARTHUR ASHER Director | 2004-11-16 17:22:28 | 250,000 0 | 250,000 | Form 4/A |
| SALOMON PETER MD Director | 2003-09-23 17:03:04 | 200,000 0 | 200,000 | Form 4 |
| HOWSON TAMAR D Director | 2011-06-24 19:19:50 | 191,722 0 | 191,722 | Form 4 |
| THOMPSON VIRGIL Director | 2011-06-24 19:23:32 | 191,722 0 | 191,722 | Form 4 |
| SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT | 2023-12-08 17:10:49 | 150,000 0 | 150,000 | Form 4 |
| ARIES FINANCIAL SERVICES INC ARIES SELECT LTD ARIES SELECT I LLC ARIES SELECT II LLC ARIES TRUST ARIES DOMESTIC FUND L P ARIES DOMESTIC FUND II L P ROSENWALD LINDSAY A MD 10% Owner | 2005-02-11 18:53:16 | 120,791 0 | 120,791 | Form 13G |
| Madison T J Director | 2006-01-12 16:05:48 | 100,000 0 | 100,000 | Form 4 |
| Donini Oreola CSO | 2023-12-08 17:12:18 | 90,000 0 | 90,000 | Form 4 |
| Guarino Jonathan L. CHIEF FINANCIAL OFFICER | 2023-12-08 17:10:16 | 90,000 0 | 90,000 | Form 4 |
| HORGAN KEVIN Chief Medical Officer & Sr. VP | 2013-09-27 17:01:10 | 85,000 0 | 85,000 | Form 4 |
| Straube Richard SENIOR VICE PRESIDENT AND CMO | 2023-12-08 17:11:36 | 75,000 0 | 75,000 | Form 4 |
| Warusz Joseph Michael VP of Finance/Acting CFO | 2016-01-04 17:31:14 | 55,000 0 | 55,000 | Form 4 |
| Krumeich Karen R SVP and CFO | 2018-12-14 16:33:38 | 40,000 0 | 40,000 | Form 4 |
| RUBIN ROBERT J. Director | 2023-12-15 16:10:14 | 38,136 0 | 38,136 | Form 4 |
| Parks Diane L. Director | 2023-12-15 16:10:19 | 38,136 0 | 38,136 | Form 4 |
| LAPOINTE ANTHONY GREGG Director | 2023-12-15 16:10:12 | 38,136 0 | 38,136 | Form 4 |
| ZELDIS JEROME B Director | 2023-12-15 16:10:21 | 38,136 0 | 38,136 | Form 4 |
| Pearson Mark E. Director 10% Owner | 2019-09-10 18:39:22 | 30,928 0 | 30,928 | Form 4 |
| Brownlie Keith L Director | 2018-09-28 17:03:39 | 17,964 0 | 17,964 | Form 4 |
| Cote Timothy R. Director | 2023-05-05 18:38:54 | 15,000 0 | 15,000 | Form 4 |
| Brughera Marco Maria Director | 2017-06-12 17:21:27 | 13,100 0 | 13,100 | Form 4 |
| BREY ROBERT N Chief Scientific Off., Sr. VP | 2013-12-09 17:14:43 | 10,000 0 | 10,000 | Form 4 |
| SEDLACK STUART D Director | 2004-11-29 16:26:33 | 0 0 | 0 | Form 3 |